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There is a large variability in dose prescription and 
normalization methods in stereotactic body radiation 
therapy (SBRT) for lung cancer. Historically an 
inhomogeneous dose was prescribed to a certain isodose-
line enclosing the planning target volume and the 
normalization was done on the maximum dose (in 
agreement with ICRU 50). The new ICRU 91 report for 
stereotactic treatments recommends prescribing and 
normalizing the dose to the isodose surface that covers 
an optimal percentage of the planning target volume 
(PTV). Independent from the method for normalization, 
only one dosimetric parameter for the target can be 
fixed, which might lead to large variations in the other 
dose-parameters. This study aimed to evaluate and 
compare different dose normalization methods, in 
particular considering the recently published ICRU 91 
report. 
Material and Methods  
Thirty-eight patients previously treated with SBRT for 
stage I NSCL or lung metastases were included in the 
study. VMAT treatment planning was performed on the 
average CT using an internal target volume (ITV) concept. 
Additionally, for each patient, a conformal arc plan (CA) 
was prepared. A dose of 40.5 Gy in 3 fractions was 
prescribed to the 65% isodose-line covering at least 95% 
of the PTV. Normalization was performed on the 
maximum dose (max normalization), which was 62.3Gy. 
Additionally all plans were re-normalized to:   
- 98% of the PTV covered with at least the prescribed 
dose of 40.5Gy (ICRU 91) (coverage normalization) 
- 100%  (52Gy) as the median PTV value (ICRU 83) 
(median PTV normalization)  
- 100% (57Gy) as the median ITV value (median ITV 
normalization) 
For the different normalization methods the inter-patient 
and inter-technique variability of several dose 
parameters (PTV and ITV median dose and dose to 98% of 
PTV and ITV) was analyzed.  Additionally it was assessed 
if volume and tumor motion could explain this variability. 
Results  
The inter-patient and inter-technique variability of the 
assessed ITV and PTV dose parameters was smallest for 
median ITV normalization (1 SD < 1.5 Gy for both 
techniques, Table 1).   
 
For normalization on the maximum dose value, the 98% 
coverage and the median PTV dose resulted in similar 
variability between patients and a significant difference 
in two out of the four dosimetric parameters between the 
two treatment techniques. For all normalization 
methods, all dosimetric parameters (except for 
normalization parameter) were correlated with the ITV 
volume and the tumor motion (Figure 1).  
 
Conclusion  
Normalization on the ITV coverage as recommended in 
ICRU 91 resulted in a similar variability between patients 
compared to the traditional normalization on the 
maximum dose and was significantly inferior to dose 
normalization to median ITV dose. Independently from 
the dose normalization method, relevant interpatient 
variability remained due to the influence of ITV volume 
as well as tumor motion. Consequently, reporting a single 
dosimetric parameter is insufficient even when using a 
strictly defined planning protocol. 
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Purpose or Objective  
The use of very high-energy (70-300 MeV) electron (VHEE) 
beams for radiation therapy has recently started to be 
explored [1,2]. The main advantages over photons 
include the fact that small diameter VHEE beams can be 
scanned, thereby producing finer resolution intensity 
modulated treatment than photon beams, a sharper 
lateral penumbra in the first centimeters and a reduced 
sensitivity to tissue heterogeneity. Along this line, the 
combination of VHEE with the benefits of Spatially 
Fractionated Radiotherapy (a significant increase in 
normal tissue tolerance [3]) has been recently proposed 
[4]. This novel approach, called VHEE grid therapy, is to 
be implemented at the future French Platform for 
Research and Applications with Electrons (PRAE). This 
facility [5] will deliver 70 MeV electron beams in a first 
phase, reaching 140 MeV in the second one. The purpose 
of this work was to define the most adequate source and 
beamline parameters for pre-clinical studies. 
Material and Methods  
Monte Carlo simulations (GATE version 7.1) were used to 
assess the dose distributions resulting from various 
possible configurations. The influence of technically 
feasible beam parameters (beam sizes, beam energies) 
achievable at PRAE facility, as well as that of various air 
gaps, were characterized (see Figure). Depth-dose curves 
and beam width were used as figures of merit. In 
addition, the influence of center-to-center (ctc) distance 
between the pencil beams was evaluated to study the 
variation in terms of peak-to-valley dose ratio (PVDR), a 
relevant dosimetric parameter for normal tissue sparing. 
Our main targets are neurological, i.e., targets that can 
be immobilized against cardio-respiratory cycles. 
Results  
Our results show the feasibility of implementing our 
strategy at PRAE. If sub-millimetric beams would be 
requested at all depths in the rat head in order to exploit 
dose-volume effects, high energies (>= 140 MeV) and low 
air-gap (<= 15 cm) would be needed. This would be 
associated with very high PVDR values over the rat brain, 
thus potential high tissue sparing could be expected. 
However, energies around 70 MeV could be used to treat 
tumors up to 1 cm depth (center of rat head, 
approximately). Experimental dosimetry measurements 
are foreseen to validate our calculations. 
Conclusion  
The present Monte-Carlo study show the potential of the 
VHEE Grid-Therapy approach to increase high normal 
tissue tolerance with technically feasible beam 
parameters achievable at PRAE. This support the interest 
of performing pre-clinical experiments to evaluate its 
therapeutic benefit to treat brain cancer. 
[1] DesRosiers C. et al., Phys. Med. Biol. 2000;45(7): 
1781–1805. 
[2] Bazalova-Carter M. et al., Med. Phys. 2015;42(5):2615 
[3] Prezado Y. et al., Radiat Res. 2015;184(3):314-321.  
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Purpose or Objective  
To develop a system that captures head-and-neck (HN) 
intensity modulated radiation therapy (IMRT) cases with 
single-lateral and bi-lateral parotid sparing decisions 
using model tree. 
Material and Methods  
Seventy-three HN IMRT cases were included in this study, 
with 45 bilateral parotid sparing (90 spared parotids) and 
28 single parotid sparing (28 spared parotids) cases. 
The model tree training: the combined set of 80 bi-
laterally and 23 single-laterally spared parotids. 
Baseline model training: 
1. bi-lateral sparing model was trained using 80 bi-
laterally spared parotids 
2. single-lateral sparing model was trained using 23 
single-laterally spared parotids. 
3. non-differentiated model was trained using the 
combined set of 80 bi-laterally and 23 single-laterally 
spared parotids 
Model evaluation: 
The remaining 10 bi-laterally spared parotids and 5 
single-laterally spared parotids were used to validate the 
model tree and the three baseline models. The 
experiment was repeated 20 times using bootstrap. The 
Weighted Sum of Residual (WSR) was used to evaluate the 
accuracy of dose-volume histogram (DVH) prediction. The 
difference between predicted and the clinically planned 
parotid D50% was assessed. 
Results  
The mean WSR of the validation bi-lateral cases was 
0.021, 0.034, 0.026 and 0.022 for the bi-lateral model, 
the single-lateral model, the non-differentiated model 
and model tree, respectively. Model tree predicted 
similarly as the bi-lateral model based on the mean WSR 
while single-lateral model predicted unfavorably for the 
bi-lateral cases. For the single-lateral validation cases, 
the mean WSR was -0.007, 0.010, -0.001 and 0.004 for 
the bi-lateral model, the single-lateral model, the non-
differentiated model and model tree, respectively. The 
mean D50% difference of 
the bi-lateral model, the single-lateral model, the non-
differentiated model and model tree were -0.40Gy, -
2.00Gy, -1.12Gy and -0.87Gy for bi-lateral cases, and 
1.63Gy, -0.13Gy, 0.89Gy and 0.60Gy for single-lateral 
cases. Model tree improved prediction accuracy for both 
bi-lateral and single-lateral cases over non-differentiated 
model. 
Conclusion  
An organ-at-risk sparing decision support system was 
proposed for HN treatment planning. Results showed the 
deficiency of using a single regression model for HN IMRT 
modeling because different parotid sparing decisions 
were involved in clinical cases. Results suggest that the 
model tree is effective in modeling HN IMRT cases with 
different parotid sparing decisions. The decision support 
system could aid make sparing decisions for HN patients 
based on patient specific anatomy. 
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Purpose or Objective  
Statistical Process Control (SPC) is a tool widely used in 
industrial engineering for monitoring, controlling and, 
ideally, improving a process through statistical analysis. 
We applied this strategy for patient-specific VMAT pre-
treatment verification. 
Material and Methods  
In the last eight years, more than 1700 patients were 
treated with Elekta VMAT at our institution. Plans were 
re-grouped according to treatment technique and disease 
sites Group 1: 736 high-modulated complex treatments 
using simultaneous integrated boost for multiple targets 
for head-neck, pelvic (high-risk prostate and 
gynaecological), brain and other sites; (2) 441 low-risk 
prostate treatments and (3) 558 liver, lung, abdominal 
and other metastasis treated with extracranial 
stereotactic radiotherapy (SBRT). Groups 1-2 and 3 plans 
were optimized with Oncentra Masterplan and Ergo++ 
TPS. A total of 4942 planar dose measurements were 
performed with the PTW Seven29 array/Octavius 
phantom, both on coronal and sagittal planes. Doses 
comparison were evaluated using 3%/3mm γ-analysis. 
Three metrics were simultaneously evaluated: (a) γ%: 
points-percentage with γ-value less than one, (b) γmean: 
mean gamma value and (c) γ1%: the near-maximum 
gamma defined as the 99th percentile of the γ-
distribution . Clinical specifications were: γ%>90%, 
γmean<0.67 and γ1%<2. Shewhart charts were used to 
calculate the central (CL), upper control (UCL) and lower 
control limits (LCL). The capability of the processes was 
evaluated by means of Cpk indexes. Processes were 
considered capable if Cpk ≥ 1. A Gage R&R study was also 
perfomed to assess the capability of our ion-camber 
device in order to quantify how it influences the 
variability of the dose delivery process. 
Results  
γ pass-rate values significantly depend on plan 
complexity. For γ%, CL and LCL were 93.8%, 99.1%, 99.5% 
and 87.9%, 96.6%, 97.9%, for group 1,2 and 3 
respectively. For γmean, CL and UCL were 0.42, 0.36, 
0.29 and 0.54, 0.49, 0.40, for groups 1, 2 and 3 
